血友病 A 中的 HLA 变异和抑制剂开发：HEMFIL 研究小组的研究结果。

{"title":"血友病 A 中的 HLA 变异和抑制剂开发：HEMFIL 研究小组的研究结果。","authors":"Márcio Antônio Portugal Santana, Daniel Gonçalves Chaves, Felipe Cb Souza, Suely Meireles Rezende","doi":"10.1016/j.htct.2024.05.015","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":94026,"journal":{"name":"Hematology, transfusion and cell therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"HLA variants and inhibitor development in hemophilia A: results from the HEMFIL study group.\",\"authors\":\"Márcio Antônio Portugal Santana, Daniel Gonçalves Chaves, Felipe Cb Souza, Suely Meireles Rezende\",\"doi\":\"10.1016/j.htct.2024.05.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":94026,\"journal\":{\"name\":\"Hematology, transfusion and cell therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hematology, transfusion and cell therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.htct.2024.05.015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hematology, transfusion and cell therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.htct.2024.05.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}